The resulting GE11-Exo-let-7a miRNA demonstrated a high affinity for EGFR-overexpressing cancer cells and significantly reduced tumor growth, highlighting the potential of GE11-modified exosomes as an effective delivery system for targeted EGFR therapy [237]. This evidence concerns the gene EGFR and neoplasm.